Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Otezla® (apremilast) – New orphan indication
July 19, 2019 - Celgene announced the FDA approval of Otezla (apremilast), for the treatment of adult patients with oral ulcers associated with Behçet’s disease (BD).
